TGA Approval

RAPIBLYK landiolol hydrochloride 300 mg powder for injection vial (463165)

ARTG ID

463165

ARTG Name

RAPIBLYK landiolol hydrochloride 300 mg powder for injection vial

Sponsor

Phebra Pty Ltd

ARTG Date

June 13, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

PHEBRA PTY LTD

Ingredient Name

landiolol hydrochloride

Empowering clinical research with data-driven insights and AI-powered tools.

RAPIBLYK landiolol hydrochloride 300 mg powder for injection vial (463165) - TGA 批准文号 | MedPath